Related Experiment Videos
Glycosylation and rheumatic disease
1Academic Unit for Musculoskeletal Disease, St. George's Hospital Medical School, University of London, UK.
Biochimica Et Biophysica Acta
|November 26, 1999
Summary
Rheumatoid arthritis involves altered immunoglobulin G galactosylation due to enzyme defects. This
Area of Science:
- Biochemistry and immunology, focusing on glycosylation.
- Rheumatology and autoimmune disease mechanisms.
Background:
- Rheumatoid arthritis (RA) is linked to significant defects in galactosyltransferase enzymes.
- These defects cause profound alterations in immunoglobulin G (IgG) galactosylation.
Purpose of the Study:
- To investigate the association between IgG galactosylation defects and RA pathogenesis.
- To explore if similar glycosylation disruptions occur in other rheumatic diseases.
Main Methods:
- Analysis of galactosyltransferase enzyme activity in patients with rheumatic diseases.
- Assessment of immunoglobulin G glycosylation patterns.
Main Results:
- A significant defect in galactosyltransferase activity was observed, leading to altered IgG galactosylation in RA.
- Evidence suggests subtle disruptions in glycosylation homeostasis may occur in other rheumatic diseases, creating unique 'sugar prints'.
Conclusions:
- Altered IgG galactosylation is integral to RA inflammation.
- The concept of 'sugar printing' rheumatic diseases may offer diagnostic and therapeutic potential.